InvestorsHub Logo
Followers 6
Posts 2507
Boards Moderated 0
Alias Born 07/21/2016

Re: None

Tuesday, 08/22/2017 10:48:03 AM

Tuesday, August 22, 2017 10:48:03 AM

Post# of 144813
Nuvilex Eyes FDA Fast Track After ABRAXANE Approved for Pancreatic Cancer
Sep 11, 2013

ONLY FOUR YEARS AGO.

PharmaCyte Biotech’s COO, Dr. Gerry Crabtree, says his company also plans to apply to have the FDA “Fast Track” its unique live-cell encapsulation-based treatment for advanced, inoperable pancreatic cancer that consists of tiny pin-head-sized capsules containing live drug-activating cells combined with the long known and widely used cancer drug, ifosfamide
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News